Questions about a paper in Science magazine led its editor in chief, Donald Kennedy, to publish an “editorial expression of concern” today that states that the report of a study about developing ...
- Results support ongoing Phase 1/2 AUGMENT-101 trial of Syndax Pharmaceuticals' lead Menin-MLL inhibitor, SNDX-5613, for the treatment of adults with relapsed/refractory acute leukemias, including ...
After 151 years, Popular Science will no longer be available to purchase as a magazine. PopSci owner Recurrent Ventures "Cathy Hebert said the outlet needed to 'evolve' beyond its magazine product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback